Pharma channel feed

Cidara buys back flu rights, sells an­ti­fun­gal and inks $240M PIPE

Last year
Financing
Deals

Fol­low­ing low­er-than-ex­pect­ed prof­its, Evotec plans to cut costs, com­pletes CEO search

Last year
People

Sen. Sanders launch­es probe of Novo's We­govy and Ozem­pic pric­ing

Last year

Neu­ro­crine launch­es CAH rare dis­ease ed­u­ca­tion cam­paign ahead of FDA sub­mis­sion

Last year
Marketing

FDA's bi­o­log­ics chief Pe­ter Marks pre­views ac­cel­er­at­ed ap­proval guid­ance

Last year
R&D
FDA+

Cure­Vac to cut costs, starts GSK-part­nered bird flu vac­cine tri­al

Last year
R&D

8 take­aways from Bio­gen’s Q1 up­date: A ‘dif­fi­cult’ launch for Leqem­bi, a $103M vouch­er and a fo­cus on new li­cens­ing deals

Last year

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Last year
China
Manufacturing

Bio­gen de­tails Leqem­bi's grad­ual com­mer­cial ramp-up

Last year

Roche dou­bles down on high-im­pact projects af­ter slash­ing 20% of its pipeline

Last year

No­var­tis brings Lu­tathera to ado­les­cents with rare can­cer in first for ra­di­oli­gand class

Last year
FDA+

FDA gives ac­cel­er­at­ed ap­proval to Day One’s tar­get­ed treat­ment for most com­mon brain tu­mor in kids

Last year
FDA+

Ver­tex li­cens­es TreeFrog’s tech to up­scale cell ther­a­py man­u­fac­tur­ing for di­a­betes can­di­dates

Last year
Deals
Manufacturing

Mar­ket­ingRx roundup: Cannes ad fes­ti­val speak­ers to in­clude Pfiz­er, No­vo Nordisk; AZ adds TV com­mer­cial to NHL col­lab

Last year
Marketing

No­var­tis’ sim­pli­fied strat­e­gy takes shape as the com­pa­ny seeks for­mer Bris­tol My­ers CEO as chair

Last year
R&D

Phar­ma com­pa­nies tone down ESG men­tions, but not am­bi­tions

Last year
Marketing

Pas­cal So­ri­ot’s been push­ing for US-sized CEO pay for more than a decade. Now he’s fi­nal­ly get­ting it

Last year
People
Bioregnum

Lil­ly nabs in­jectable med­i­cines fa­cil­i­ty from Nexus Phar­ma

Last year
Manufacturing

One bid­der and a $5 hike: How Ver­tex inked $4.9B Alpine deal

Last year
Deals

No­var­tis will change CRO re­la­tion­ships ‘over time’ as Sen­ate bill tar­get­ing Chi­nese com­pa­nies looms

Last year

Weeks af­ter clos­ing Bris­tol My­ers deal, Karuna's ex-CEO heads to Black­stone-backed An­thos

Last year
People

Re­gen­eron’s $500M fund spot­lights cor­po­rate ven­ture’s in­flu­en­tial role in biotech

Last year
Financing
Startups

Mar­ket­ing pay­ments to can­cer doc­tors lead to more pre­scrip­tions but not bet­ter out­comes, NBER pa­per finds

Last year
Marketing

Car­di­nal Health los­es Op­tum­Rx con­tract to McKesson

Last year
First page Previous page 57585960616263 Next page Last page
A service from the Financial Times